Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | CEVP General Counsel & CCO | May 29, 2020 | June 02, 2020 |
| Mirion Technologies, Inc.MIR · Entity 394 | Director | May 13, 2026 | May 14, 2026 |
| VARIAN MEDICAL SYSTEMS INCVAR · Entity 140252 | SVP, Gen Counsel and Secretary | February 18, 2020 | February 20, 2020 |
| Varex Imaging CorpVREX · Entity 5135 | Director | January 19, 2017 | January 20, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 29, 2020 · Filed June 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,171 |
Ending reported balance
After 2020-06-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-05-29 · Grant · Acquired 1,781 · Balance 1,781 F1: Unvested restricted stock units vest as follows: 445 on May 29, 2021, 445 on May 29, 2022, 445 on May 29, 2023 and 446 May 29, 2024. Row 2 · 2020-06-01 · Grant · Acquired 1,390 · Balance 3,171 F2: Unvested restricted stock units vest as follows: 695 on June 1, 2021 and 695 on June 1, 2022. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $179.66 · Expires 2030-05-29 | Direct | 5,942 |
Reported balance
After 2020-05-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-05-29 · Grant · Acquired 5,942 · Balance 5,942 F3: Stock Options vest as follows: 1,485 on May 29, 2021, 1,486 on May 29, 2022, 1,485 on May 29, 2023 and 1,486 on May 29, 2024. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $179.82 · Expires 2030-06-01 | Direct | 4,636 |
Reported balance
After 2020-06-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-06-01 · Grant · Acquired 4,636 · Balance 4,636 F4: Stock Options vest as follows: 2,318 on June 1, 2021 and 2,318 on June 1, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested restricted stock units vest as follows: 445 on May 29, 2021, 445 on May 29, 2022, 445 on May 29, 2023 and 446 May 29, 2024.
F2: Unvested restricted stock units vest as follows: 695 on June 1, 2021 and 695 on June 1, 2022.
F3: Stock Options vest as follows: 1,485 on May 29, 2021, 1,486 on May 29, 2022, 1,485 on May 29, 2023 and 1,486 on May 29, 2024.
F4: Stock Options vest as follows: 2,318 on June 1, 2021 and 2,318 on June 1, 2022.
Mirion Technologies, Inc.
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 80,119 |
Reported balance
After 2026-05-13 transaction · row 1
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 7,383 · Balance 80,119 F1: Represents restricted stock units that will vest on the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that will vest on the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through such vesting date.
VARIAN MEDICAL SYSTEMS INC
Report date February 18, 2020 · Filed February 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,269 |
Ending reported balance
After 2020-02-18 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2020-02-18 · Exercise / conversion · Acquired 1,120 · Balance 39,679 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 2 · 2020-02-18 · Exercise / conversion · Acquired 798 · Balance 40,477 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 3 · 2020-02-18 · Exercise / conversion · Acquired 683 · Balance 41,160 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 4 · 2020-02-18 · Tax withholding · Disposed 891 · Balance 40,269 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,645 |
Reported balance
After 2020-02-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-02-18 · Exercise / conversion · Disposed 1,120 · Balance 3,645 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,847 |
Reported balance
After 2020-02-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-02-18 · Exercise / conversion · Disposed 798 · Balance 2,847 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,164 |
Reported balance
After 2020-02-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-02-18 · Exercise / conversion · Disposed 683 · Balance 2,164 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F2: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date.
F3: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date.
F4: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date.
Varex Imaging Corp
Report date January 19, 2017 · Filed January 20, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| No securities are beneficially owned.SEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2017-01-19 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2026 Filed May 14, 2026 20:07 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 7,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035090 · wk-form4_1778789236.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,119 F1 · shares: Represents restricted stock units that will vest on the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through such vesting date. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:06 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GiftClass A Common Stock | 4,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-056760 · wk-form4_1765573613.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,736 F1 · shares: On December 11, 2025, the Reporting Person made a gift of 4,860 shares of Class A Common Stock to a donor advised fund. The Reporting Person received no consideration for the gift. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 20:00 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 1,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001330270-25-000005 · wk-form4_1751400029.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,596 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| May 15, 2025 Filed May 16, 2025 20:13 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 7,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026271 · wk-form4_1747426418.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,572 F1 · shares: Represents restricted stock units that will vest in four equal quarterly installments on September 15, 2025, December 15, 2025, March 15, 2026, and the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through each such vesting date. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 20:46 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-015948 · wk-form4_1743540402.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,595 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 22:03 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 1,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-000093 · wk-form4_1735855426.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,075 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:59 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GiftClass A Common Stock | 8,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-051697 · wk-form4_1734472754.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,788 F1 · kind: Represents a bona fide gift of shares of Class A Common Stock to a charitable donor advised fund. Read SEC document |
| September 30, 2024 Filed Jan 2, 2025 22:03 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 2,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-000093 · wk-form4_1735855426.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,801 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:02 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 2,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-030788 · wk-form4_1719950569.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,088 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| June 04, 2024 Filed Jun 4, 2024 20:47 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 13,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026614 · wk-form4_1717534022.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,069 F1 · shares: Represents restricted stock units that will vest in four equal quarterly installments on September 15, 2024, December 15, 2024, March 15, 2025, and the earlier to occur of (i) first anniversary of the grant date or (ii) date of the annual stockholder meeting following the grant date, subject to the non-employee director's continued service on the Board through each such vesting date. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:30 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 1,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-014157 · wk-form4_1712007029.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,569 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:47 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 2,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-000229 · wk-form4_1704318415.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,671 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 20:04 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 2,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-033476 · wk-form4_1696277065.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,596 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:10 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 2,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-024345 · wk-form4_1688595044.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,690 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 21:12 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 11,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-021324 · wk-form4_1686172336.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,044 F1 · shares: Represents restricted stock units that will vest in four equal quarterly installments on September 15, 2023, December 15, 2023, March 15, 2024, and June 15, 2024, subject to the non-employee director's continued service on the Board through each such vesting date. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:22 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 2,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-010696 · wf-form4_168064333817636.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,194 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 23:06 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantClass A Common Stock | 3,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000112 · wf-form4_167278717294378.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,598 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 21:00 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantCommon Stock | 2,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-025878 · wf-form4_166483081914947.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,390 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 20:55 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantCommon Stock | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-018395 · wf-form4_165670891316140.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,404 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his or her quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:17 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantCommon Stock | 14,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-017430 · wf-form4_165549700402533.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,702 F1 · shares: Represents restricted stock units that will vest in four equal quarterly installments on September 15, 2022, December 15, 2022, March 15, 2023, and June 15, 2023, subject to the non-employee director's continued service on the Board through each such vesting date. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:38 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantCommon Stock | 2,611 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-005991 · dp170622_4-kuo.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,428 F1 · shares: These shares were issued in connection with the Reporting Person's election to receive his quarterly retainer for director services in the form of vested shares rather than cash. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 22:18 UTC | Mirion Technologies, Inc. MIR · Entity 394 | GrantCommon Stock | 5,817 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-020503 · dp164361_4-kuo.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,817 F1 · shares: Represents restricted stock units ("RSUs") that will vest in two installments with 3,569 RSUs vesting on March 15, 2022 and 2,248 RSUs vesting on June 15, 2022, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 18:04 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 4,636 | $0.00 Strike: $179.82 | $0.00 |
DisclosureSEC source: 0001127602-20-018377 · form4.xml · derivative · entry 4 KUO JOHN W · CIK 0001330270 · CEVP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,636 Underlying: Common Stock · 4,636 shares Expires 2030-06-01 F4 · shares: Stock Options vest as follows: 2,318 on June 1, 2021 and 2,318 on June 1, 2022. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 18:04 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018377 · form4.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · CEVP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,171 F2 · shares: Unvested restricted stock units vest as follows: 695 on June 1, 2021 and 695 on June 1, 2022. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 18:04 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 5,942 | $0.00 Strike: $179.66 | $0.00 |
DisclosureSEC source: 0001127602-20-018377 · form4.xml · derivative · entry 3 KUO JOHN W · CIK 0001330270 · CEVP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,942 Underlying: Common Stock · 5,942 shares Expires 2030-05-29 F3 · shares: Stock Options vest as follows: 1,485 on May 29, 2021, 1,486 on May 29, 2022, 1,485 on May 29, 2023 and 1,486 on May 29, 2024. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 18:04 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018377 · form4.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · CEVP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,781 F1 · shares: Unvested restricted stock units vest as follows: 445 on May 29, 2021, 445 on May 29, 2022, 445 on May 29, 2023 and 446 May 29, 2024. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 683 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006766 · form4.xml · derivative · entry 7 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,164 Underlying: Common Stock · 683 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date. F4 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2020, February 15, 2021, and February 15, 2022. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006766 · form4.xml · derivative · entry 6 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,847 Underlying: Common Stock · 798 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2019, February 15, 2020, and February 15, 2021. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,120 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006766 · form4.xml · derivative · entry 5 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,645 Underlying: Common Stock · 1,120 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 891 | $145.90 | $129,996.90 |
DisclosureSEC source: 0001127602-20-006766 · form4.xml · nonDerivative · entry 4 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,269 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 683 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006766 · form4.xml · nonDerivative · entry 3 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006766 · form4.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 19:40 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,120 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006766 · form4.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 19:33 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 349 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001127602-19-035460 · form4.xml · derivative · entry 6 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,890 Underlying: Common Stock · 349 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 19:33 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 465 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-19-035460 · form4.xml · derivative · entry 5 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 930 Underlying: Common Stock · 465 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 19:33 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 465 | $142.61 | $66,314.91 |
DisclosureSEC source: 0001127602-19-035460 · form4.xml · nonDerivative · entry 4 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,559 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 465 shares were sold in multiple transactions executed on the same day at prices ranging from $142.00 to $142.95. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 19:33 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 349 | $141.12 | $49,250.88 |
DisclosureSEC source: 0001127602-19-035460 · form4.xml · nonDerivative · entry 3 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,024 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 19:33 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 349 | $112.82 | $39,374.18 |
DisclosureSEC source: 0001127602-19-035460 · form4.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 19:33 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 465 | $80.40 | $37,386.00 |
DisclosureSEC source: 0001127602-19-035460 · form4.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 18:09 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 2,443 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001127602-19-035091 · form4.xml · derivative · entry 3 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,239 Underlying: Common Stock · 2,443 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 18:09 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 2,443 | $142.00 | $346,906.00 |
DisclosureSEC source: 0001127602-19-035091 · form4.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,559 F2 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 18:09 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,443 | $112.82 | $275,619.26 |
DisclosureSEC source: 0001127602-19-035091 · form4.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 17:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 2,957 | $129.97 | $384,321.29 |
DisclosureSEC source: 0001127602-19-033690 · form4.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,559 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 17:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 6,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-033690 · form4.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,516 F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted on December 8, 2016. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:57 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 465 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-19-033321 · form4.xml · derivative · entry 5 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,395 Underlying: Common Stock · 465 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F6 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:57 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 348 | $128.55 | $44,735.40 |
DisclosureSEC source: 0001127602-19-033321 · form4.xml · nonDerivative · entry 4 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,103 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · price: The 348 shares were sold in multiple transactions executed on the same day at prices ranging from $127.88 to $128.85. The detailed breakdown of executed sales will be furnished upon request CancelAttach F5 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 2 shares purchased October 25, 2019 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:57 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 72 | $126.90 | $9,136.80 |
DisclosureSEC source: 0001127602-19-033321 · form4.xml · nonDerivative · entry 3 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,451 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 72 shares were sold in multiple transactions executed on the same day at prices ranging from $126.555 to $127.235. The detailed breakdown of executed sales will be furnished upon request CancelAttach Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:57 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 45 | $125.74 | $5,658.30 |
DisclosureSEC source: 0001127602-19-033321 · form4.xml · nonDerivative · entry 2 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,523 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 45 shares were sold in multiple transactions executed on the same day at prices ranging from $125.02 to $125.76. The detailed breakdown of executed sales will be furnished upon request CancelAttach Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:57 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 465 | $80.40 | $37,386.00 |
DisclosureSEC source: 0001127602-19-033321 · form4.xml · nonDerivative · entry 1 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 18:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 465 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-19-030755 · form4.xml · derivative · entry 3 KUO JOHN W · CIK 0001330270 · SVP, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,860 Underlying: Common Stock · 465 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan. F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.